Dulcolax and Gemcitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dulcolax (bisacodyl) and Gemcitabine (gemcitabine). Common drug interactions include nausea among females and deep vein thrombosis among males.

The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Gemcitabine. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Dulcolax?

Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

On Jul, 19, 2026

61 people who take Dulcolax and Gemcitabine together, and have interactions are studied.

Dulcolax and Gemcitabine drug interactions.

What are the common drug interactions of Dulcolax and Gemcitabine, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Abdominal pain
Intestinal perforation (complete penetration of the wall of the intestine)
Dyspnoea (difficult or laboured respiration)
Cholecystitis (infection of gallbladder)
Decreased appetite
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fatigue (feeling of tiredness)
Purpura (purplish discoloration of the skin)
Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)

male:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Nausea (feeling of having an urge to vomit)
Lung infection
Pleural infection (infection of membrane of lungs)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Tumour pain
Cardiac arrest
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Death
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the common drug interactions of Dulcolax and Gemcitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pancreas infection
Cardiac arrest
Death

40-49:

Dyspnoea (difficult or laboured respiration)
Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Muscular weakness (muscle weakness)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Fatigue (feeling of tiredness)
Rash
Transaminases increased

50-59:

Abdominal pain
Cholecystitis (infection of gallbladder)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Pulmonary embolism (blockage of the main artery of the lung)
Vomiting

60+:

Nausea (feeling of having an urge to vomit)
Vomiting
Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
Asthenia (weakness)
Fatigue (feeling of tiredness)
Hypokalaemia (low potassium)
Lung abscess (pus in lungs)
Lung infection
Pleural infection (infection of membrane of lungs)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

What are the existing conditions these people have? *

Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 21 people, 34.43%
Pain: 16 people, 26.23%
High Blood Pressure: 12 people, 19.67%
Nausea (feeling of having an urge to vomit): 11 people, 18.03%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 9 people, 14.75%
Pancreatic Carcinoma (pancreatic cancer): 9 people, 14.75%
Abdominal Pain: 6 people, 9.84%
Fever: 5 people, 8.20%
Diabetes: 5 people, 8.20%
Nausea And Vomiting: 4 people, 6.56%

* Approximation only. Some reports may have incomplete information.

Do you take Dulcolax and Gemcitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously